{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:24:51Z","timestamp":1783689891689,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T00:00:00Z","timestamp":1658534400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","elsevier.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nrleng.2022.06.002","type":"journal-article","created":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T14:21:34Z","timestamp":1658586094000},"page":"743-748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The prevalence, incidence, and clinical assessment of neuromyelitis optica spectrum disorder in patients with demyelinating diseases"],"prefix":"10.1016","volume":"39","author":[{"given":"M.A.","family":"Mireles-Ram\u00edrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.E.","family":"Vel\u00e1zquez-Brizuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"S\u00e1nchez-Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"M\u00e1rquez-Pedroza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Hernandez-Preciado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gabriel Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2022.06.002_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","article-title":"Pathology of demyelinating diseases","volume":"7","author":"Popescu","year":"2012","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0010","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00019052-200106000-00001","article-title":"Classification of demyelinating diseases at the interface between etiology and pathogenesis","volume":"14","author":"Lassmann","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0020","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain","volume":"4","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0030","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1007\/s00415-017-8445-8","article-title":"What\u2019s new in neuromyelitis optica? A short review for the clinical neurologist","volume":"264","author":"Whittam","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin Med (Northfield Il)"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0040","first-page":"1","article-title":"Medici\u00f3n de las condiciones de salud y enfermedad de la pobalcion","volume":"3","author":"OPS","year":"2011","journal-title":"M\u00f3dulo Principios Epidemiol para el Control Enfermedades (MOPECE)"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0050","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/ene.14079","article-title":"A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary","volume":"27","author":"Papp","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0060","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic\u2019s disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0065","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.msard.2017.10.015","article-title":"Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence","volume":"19","author":"Hor","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0075","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1177\/1352458514537699","article-title":"An epidemiological study of neuromyelitis optica in Isfahan","volume":"20","author":"Etemadifar","year":"2014","journal-title":"Mult Scler J"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult Scler J"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0095","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0105","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1212\/WNL.0000000000007746","article-title":"Epidemiology of NMOSD in Sweden from 1987 to 2013: a nationwide population-based study","volume":"93","author":"Jonsson","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nrleng.2022.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10072-019-04230-6","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina : comparing baseline data from the Argentinean MS Registry (RelevarEM)","volume":"41","author":"Rojas","year":"2020","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0115","article-title":"Clinical and radiological profile of neuromyelitis optica spectrum disorders in an Ecuadorian cohort","volume":"44","author":"Correa D\u00edaz","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2020.00501","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of neuromyelitis optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000225","article-title":"Neuromyelitis optica spectrum disorders: comparison according to the phenotype and serostatus","volume":"3","author":"Sep\u00falveda","year":"2016","journal-title":"Neurol Neuroimmunol NeuroInflamm"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0140","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/ane.12903","article-title":"Incidence of neuromyelitis optica spectrum disorder in the Central Denmark Region","volume":"137","author":"Dale","year":"2018","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0145","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0150","first-page":"204","article-title":"A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran","volume":"14","author":"Kashipazha","year":"2015","journal-title":"Iran J Neurol"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0155","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1093\/jamia\/ocab202","article-title":"Enhancing the use of EHR systems for pragmatic embedded research: lessons from the NIH Health Care Systems Research Collaboratory","volume":"28","author":"Richesson","year":"2021","journal-title":"J Am Med Informatics Assoc"},{"key":"10.1016\/j.nrleng.2022.06.002_bib0160","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-90-481-9485-8_6","article-title":"Patient registries: utility, validity and inference","volume":"686","author":"Richesson","year":"2010","journal-title":"Adv Exp Med Biol"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580822000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580822000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T12:18:52Z","timestamp":1733401132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580822000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2173580822000797"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2022.06.002","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prevalence, incidence, and clinical assessment of neuromyelitis optica spectrum disorder in patients with demyelinating diseases","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2022.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Neurolog\u00eda.","name":"copyright","label":"Copyright"}]}}